Cytek Biosciences, Inc. CTKB China — Total revenue, net
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s china — total revenue, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s china — total revenue, net?
- Cytek Biosciences, Inc. (CTKB) reported china — total revenue, net of $3.6M in Q1 2026.
- How has Cytek Biosciences, Inc.'s china — total revenue, net changed year-over-year?
- Cytek Biosciences, Inc.'s china — total revenue, net decreased by 32.1% year-over-year, from $5.3M to $3.6M.
- What does china — total revenue, net mean?
- This metric represents the total net revenue generated from sales of instruments, reagents, and services within the China geographic market. It serves as a key indicator of the company's market penetration and adoption rates for its full-spectrum flow cytometry technology in this specific region. Monitoring this figure helps investors assess the company's international growth strategy and its competitive positioning within the rapidly expanding Chinese life sciences sector.